International Company For Medical Industries S.A.E. (EGX: ICMI)
Egypt
· Delayed Price · Currency is EGP 0.00
0.00 (0.00%)
No quote available
EGX: ICMI Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 34.77 | 34.77 | 11.97 | 1.07 | 2.19 | 6.19 | Upgrade
|
| Revenue Growth (YoY) | 190.46% | 190.46% | 1013.95% | -50.92% | -64.61% | -7.39% | Upgrade
|
| Cost of Revenue | 27.45 | 27.45 | 9.37 | 1.33 | 1.88 | 5.73 | Upgrade
|
| Gross Profit | 7.32 | 7.32 | 2.6 | -0.26 | 0.31 | 0.46 | Upgrade
|
| Selling, General & Admin | 10.74 | 10.74 | 2.88 | 0.2 | 0.33 | 0.36 | Upgrade
|
| Operating Expenses | 10.74 | 10.74 | 2.89 | 0.23 | 0.36 | 0.36 | Upgrade
|
| Operating Income | -3.43 | -3.43 | -0.29 | -0.49 | -0.04 | 0.1 | Upgrade
|
| Interest Expense | - | - | -0.02 | -0.11 | -0.07 | -0.05 | Upgrade
|
| Interest & Investment Income | 0.03 | 0.03 | 1.24 | - | - | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.12 | -1.12 | -0.06 | -0 | 0.13 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | -4.51 | -4.51 | 0.87 | -0.6 | 0.02 | 0.05 | Upgrade
|
| Gain (Loss) on Sale of Investments | -6.15 | -6.15 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 12.35 | 12.35 | - | 0.55 | - | - | Upgrade
|
| Pretax Income | 1.68 | 1.68 | 0.87 | -0.05 | 0.02 | 0.05 | Upgrade
|
| Income Tax Expense | 0.05 | 0.05 | -0.05 | 0.04 | -0.02 | 0 | Upgrade
|
| Earnings From Continuing Operations | 1.64 | 1.64 | 0.92 | -0.09 | 0.03 | 0.05 | Upgrade
|
| Minority Interest in Earnings | -0.18 | -0.18 | - | - | - | - | Upgrade
|
| Net Income | 1.46 | 1.46 | 0.92 | -0.09 | 0.03 | 0.05 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.01 | 0.01 | Upgrade
|
| Net Income to Common | 1.46 | 1.46 | 0.92 | -0.09 | 0.03 | 0.04 | Upgrade
|
| Net Income Growth | 58.93% | 58.93% | - | - | -27.61% | -87.84% | Upgrade
|
| Shares Outstanding (Basic) | - | - | 58 | 24 | 24 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | - | - | 58 | 24 | 24 | 24 | Upgrade
|
| Shares Change (YoY) | - | - | 138.41% | - | - | - | Upgrade
|
| EPS (Basic) | - | - | 0.02 | -0.00 | 0.00 | 0.00 | Upgrade
|
| EPS (Diluted) | - | - | 0.02 | -0.00 | 0.00 | 0.00 | Upgrade
|
| EPS Growth | - | - | - | - | -27.59% | -87.85% | Upgrade
|
| Free Cash Flow | 11.45 | 11.45 | -21.74 | -1.08 | -1.35 | -1.6 | Upgrade
|
| Free Cash Flow Per Share | - | - | -0.38 | -0.04 | -0.06 | -0.07 | Upgrade
|
| Gross Margin | 21.04% | 21.04% | 21.73% | -24.04% | 14.34% | 7.44% | Upgrade
|
| Operating Margin | -9.86% | -9.86% | -2.39% | -45.29% | -1.96% | 1.65% | Upgrade
|
| Profit Margin | 4.20% | 4.20% | 7.67% | -8.50% | 1.26% | 0.62% | Upgrade
|
| Free Cash Flow Margin | 32.93% | 32.93% | -181.58% | -100.73% | -61.70% | -25.80% | Upgrade
|
| EBITDA | -0.04 | -0.04 | 0.54 | 0.34 | 0.79 | 0.89 | Upgrade
|
| EBITDA Margin | -0.11% | -0.11% | 4.50% | 31.56% | 36.05% | 14.43% | Upgrade
|
| D&A For EBITDA | 3.39 | 3.39 | 0.83 | 0.83 | 0.83 | 0.79 | Upgrade
|
| EBIT | -3.43 | -3.43 | -0.29 | -0.49 | -0.04 | 0.1 | Upgrade
|
| EBIT Margin | -9.86% | -9.86% | -2.39% | -45.29% | -1.96% | 1.65% | Upgrade
|
| Effective Tax Rate | 2.70% | 2.70% | - | - | - | 9.33% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.